NasdaqGS - Nasdaq Real Time Price USD

IDEXX Laboratories, Inc. (IDXX)

510.73
+1.31
+(0.26%)
As of 12:28:51 PM EDT. Market Open.
Loading Chart for IDXX
  • Previous Close 509.42
  • Open 508.08
  • Bid 465.22 x 200
  • Ask 547.79 x 200
  • Day's Range 505.00 - 512.16
  • 52 Week Range 356.14 - 547.22
  • Volume 145,404
  • Avg. Volume 880,260
  • Market Cap (intraday) 41.074B
  • Beta (5Y Monthly) 1.52
  • PE Ratio (TTM) 47.29
  • EPS (TTM) 10.80
  • Earnings Date Aug 4, 2025 - Aug 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 497.46

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference laboratory diagnostic and consulting services to veterinarians; veterinary consultation, telemedicine, and advisory services, including radiology, dental radiography, cardiology, internal medicine, and ultrasound consulting; Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, Quanti-Tray products, and Tecta system instruments; and veterinary software and services for independent veterinary clinics and corporate groups. In addition, it offers diagnostic tests, services, and related instrumentation for manage the health status of livestock and poultry; human medical diagnostic products and services; and VetConnect PLUS, a cloud-based technology that enables veterinarians to access and analyze patients, as well as operates VetLab Station. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

www.idexx.com

11,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IDXX

View More

Performance Overview: IDXX

Trailing total returns as of 5/15/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IDXX
23.53%
S&P 500 (^GSPC)
0.40%

1-Year Return

IDXX
6.89%
S&P 500 (^GSPC)
11.25%

3-Year Return

IDXX
41.02%
S&P 500 (^GSPC)
46.75%

5-Year Return

IDXX
73.49%
S&P 500 (^GSPC)
106.21%

Compare To: IDXX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IDXX

View More

Valuation Measures

Annual
As of 5/14/2025
  • Market Cap

    40.97B

  • Enterprise Value

    41.86B

  • Trailing P/E

    47.08

  • Forward P/E

    42.19

  • PEG Ratio (5yr expected)

    4.21

  • Price/Sales (ttm)

    10.72

  • Price/Book (mrq)

    28.29

  • Enterprise Value/Revenue

    10.65

  • Enterprise Value/EBITDA

    32.47

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    22.76%

  • Return on Assets (ttm)

    22.98%

  • Return on Equity (ttm)

    59.33%

  • Revenue (ttm)

    3.93B

  • Net Income Avi to Common (ttm)

    894.96M

  • Diluted EPS (ttm)

    10.80

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    163.97M

  • Total Debt/Equity (mrq)

    73.16%

  • Levered Free Cash Flow (ttm)

    761.15M

Research Analysis: IDXX

View More

Company Insights: IDXX

Research Reports: IDXX

View More

People Also Watch